MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - indian pharma
- CADILA HEALTHCARE - ACTAVIS (US)
CADILA HEALTHCARE vs ACTAVIS (US) - Comparison Results
CADILA HEALTHCARE Change
Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More
ACTAVIS (US)
Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More
Financials
 CADILA HEALTHCARE  ACTAVIS |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| CADILA HEALTHCARE Mar-20 |
ACTAVIS Dec-18 |
CADILA HEALTHCARE/ ACTAVIS |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 352 | 14,247 | - | |
| Low | Rs | 207 | 9,557 | - | |
| Sales per share (Unadj.) | Rs | 139.2 | 3,494.9 | - | |
| Earnings per share (Unadj.) | Rs | 11.8 | -1,125.7 | - | |
| Cash flow per share (Unadj.) | Rs | 18.6 | 368.3 | - | |
| Dividends per share (Unadj.) | Rs | 3.50 | 0 | - | |
| Dividend yield (eoy) | % | 1.3 | 0 | - | |
| Book value per share (Unadj.) | Rs | 101.4 | 14,414.7 | - | |
| Shares outstanding (eoy) | m | 1,023.74 | 332.60 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 2.0 | 3.4 | 58.9% | |
| Avg P/E ratio | x | 23.7 | -10.6 | -224.6% | |
| P/CF ratio (eoy) | x | 15.0 | 32.3 | 46.6% | |
| Price / Book Value ratio | x | 2.8 | 0.8 | 333.9% | |
| Dividend payout | % | 29.8 | 0 | - | |
| Avg Mkt Cap | Rs m | 286,033 | 3,958,701 | 7.2% | |
| No. of employees | `000 | 13.4 | 16.9 | 79.3% | |
| Total wages/salary | Rs m | 24,145 | 0 | - | |
| Avg. sales/employee | Rs Th | 10,632.7 | 68,780.9 | 15.5% | |
| Avg. wages/employee | Rs Th | 1,801.2 | 0 | - | |
| Avg. net profit/employee | Rs Th | 898.5 | -22,154.4 | -4.1% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 142,531 | 1,162,397 | 12.3% | |
| Other income | Rs m | 1,139 | 22,229 | 5.1% | |
| Total revenues | Rs m | 143,670 | 1,184,626 | 12.1% | |
| Gross profit | Rs m | 24,198 | 30,461 | 79.4% | |
| Depreciation | Rs m | 6,965 | 496,899 | 1.4% | |
| Interest | Rs m | 3,418 | 67,077 | 5.1% | |
| Profit before tax | Rs m | 14,954 | -511,287 | -2.9% | |
| Minority Interest | Rs m | 288 | 0 | - | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 130,399 | 0.0% | |
| Tax | Rs m | 3,198 | -6,479 | -49.4% | |
| Profit after tax | Rs m | 12,044 | -374,409 | -3.2% | |
| Gross profit margin | % | 17.0 | 2.6 | 647.9% | |
| Effective tax rate | % | 21.4 | 1.3 | 1,687.5% | |
| Net profit margin | % | 8.5 | -32.2 | -26.2% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 87,154 | 476,754 | 18.3% | |
| Current liabilities | Rs m | 82,694 | 421,753 | 19.6% | |
| Net working cap to sales | % | 3.1 | 4.7 | 66.1% | |
| Current ratio | x | 1.1 | 1.1 | 93.2% | |
| Inventory Days | Days | 71 | 20 | 364.7% | |
| Debtors Days | Days | 94 | 66 | 141.5% | |
| Net fixed assets | Rs m | 133,236 | 131,577 | 101.3% | |
| Share capital | Rs m | 1,024 | 0 | - | |
| Net worth | Rs m | 103,757 | 4,794,344 | 2.2% | |
| Long term debt | Rs m | 32,146 | 1,688,262 | 1.9% | |
| Total assets | Rs m | 236,866 | 7,494,650 | 3.2% | |
| Interest coverage | x | 5.4 | -6.6 | -81.2% | |
| Debt to equity ratio | x | 0.3 | 0.4 | 88.0% | |
| Sales to assets ratio | x | 0.6 | 0.2 | 388.0% | |
| Return on assets | % | 6.5 | -4.1 | -159.2% | |
| Return on equity | % | 11.6 | -7.8 | -148.6% | |
| Return on capital | % | 13.7 | -4.8 | -283.6% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 25,054 | 415,281 | 6.0% | |
| From Investments | Rs m | -10,123 | 228,143 | -4.4% | |
| From Financial Activity | Rs m | -10,942 | -712,746 | 1.5% | |
| Net Cashflow | Rs m | 3,989 | -68,977 | -5.8% | |
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.63 Rs / USD
Compare CADILA HEALTHCARE With: ADCOCK INGRAM (S. Africa) MYLAN (US) TEVA PHARMA (Israel)
Compare CADILA HEALTHCARE With: FDC AUROBINDO PHARMA DISHMAN PHARMA ABBOTT INDIA PFIZER
Today's Market
Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)
Indian share markets witnessed positive trading activity throughout the day today and ended higher.
Related Views On News
CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)
Feb 10, 2021 | Updated on Feb 10, 2021For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.
CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)
Oct 26, 2020 | Updated on Oct 26, 2020Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.
CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)
Aug 21, 2020 | Updated on Aug 21, 2020For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.
Why Did Alembic Pharma Shares Fall Today? (Views On News)
May 5, 2021Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.
More Views on NewsMost Popular
Time to Buy Smallcaps? (Fast Profits Daily)
Apr 30, 2021In this video, I'll show you why I favour smallcaps over the Nifty.
The Next Smallcap Winners (Profit Hunter)
Apr 30, 2021Price is the only due diligence one might require to buy this business.
Sell in May and Go Away? (Fast Profits Daily)
Apr 28, 2021Does the concept of selling stocks in the month of May, work in the Indian market?
This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)
Apr 26, 2021Should you invest with this Rockstar fund manager who has outperformed in a big way?
More
